Add-on Acquisition • Medical Products

Alfa Aesar & Co KG Acquires Biomedical Technologies

On September 16, 2013, Alfa Aesar & Co KG acquired medical products company Biomedical Technologies

Acquisition Context

This is Alfa Aesar & Co KG’s 1st transaction in the Medical Products sector.
This is Alfa Aesar & Co KG’s 1st transaction in the United States.
This is Alfa Aesar & Co KG’s 1st transaction in Massachusetts.

Explore All 2731 Add-on Acquisition Medical Products Deals - Search the Database Free

M&A Deal Summary
Date	September 16, 2013
Target	Biomedical Technologies
Sector	Medical Products
Buyer(s)	Alfa Aesar & Co KG
Deal Type	Add-on Acquisition

Target Company

Biomedical Technologies

Stoughton, Massachusetts, United States

BTI has been manufacturing life science research products for more than 30 years, with a commitment to its customers of technology, quality and value. Its product line includes specialty proteins, cell culture additives and highly specific immunoassay tools, which Alfa Aesar will continue to build upon as it expands its portfolio of unique biochemical products for the researcher.

Explore More Deals

Browse All 215,158 Deals

FILTER BY

Buyer Type (PE or Strategic)
Deal Size ($10M to $10B+)
Sector (60 Sectors)
Deal Type
Geography
& More

Search Free

Buyer Overview 1

Buyer

Alfa Aesar & Co KG

Karlsruhe, Germany

Category	Company
Sector	Chemicals
Employees	480
Revenue	78M GBP (2014)

DESCRIPTION

Alfa Aesar GmbH & Co KG is a manufacturer and supplier of research chemicals.

Deal Context for Buyer	#
Overall	1 of 1
Sector: Medical Products	1 of 1
Type: Add-on Acquisition	1 of 1
State: Massachusetts	1 of 1
Country: United States	1 of 1
Year: 2013	1 of 1

Explore Related M&A Activity

Medical Products M&A - Add-on Acquisition M&A Deals - Massachusetts M&A - United States M&A - 2013 M&A